Close
Back to SAGE Stock Lookup

SAGE Therapeutics (SAGE) – Major News

Feb 14, 2024 06:31 AM SAGE Therapeutics (SAGE) Tops Q4 EPS by 73c
Nov 7, 2023 06:34 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 69c
Aug 7, 2023 06:44 AM SAGE Therapeutics (SAGE) Misses Q2 EPS by 13c
May 2, 2023 06:34 AM SAGE Therapeutics (SAGE) Tops Q1 EPS by 4c
Feb 16, 2023 07:17 AM SAGE Therapeutics (SAGE) Misses Q4 EPS by 10c
Nov 8, 2022 06:34 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 9c
Aug 2, 2022 06:34 AM SAGE Therapeutics (SAGE) Reports In-Line Q2 EPS
May 3, 2022 06:40 AM SAGE Therapeutics (SAGE) Reports Q1 Net Loss of $122.1M
Feb 24, 2022 06:39 AM SAGE Therapeutics (SAGE) Tops Q4 EPS by 4c
Nov 2, 2021 06:40 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 36c, Reports $1.8B of Cash on Hand
Aug 3, 2021 06:40 AM SAGE Therapeutics (SAGE) Misses Q2 EPS by 14c
May 4, 2021 07:16 AM SAGE Therapeutics (SAGE) Tops Q1 EPS by 27c, Revenues Miss
Feb 24, 2021 06:39 AM SAGE Therapeutics (SAGE) Tops Q4 EPS by $18.54, Revenues Beat
Aug 10, 2020 06:32 AM SAGE Therapeutics (SAGE) Tops Q2 EPS by 3c
May 7, 2020 05:39 PM SAGE Therapeutics (SAGE) Tops Q1 EPS by 70c, Revenues Miss
Feb 27, 2020 06:43 AM SAGE Therapeutics (SAGE) Tops Q4 EPS by 36c, Revenues Miss
Nov 12, 2019 06:35 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 12c
Aug 6, 2019 06:45 AM SAGE Therapeutics (SAGE) Tops Q2 EPS by 5c
May 2, 2019 06:34 AM SAGE Therapeutics (SAGE) Misses Q1 EPS by 12c
Feb 19, 2019 06:32 AM SAGE Therapeutics (SAGE) Misses Q4 EPS by 46c
Nov 6, 2018 06:37 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 21c
Aug 7, 2018 06:34 AM SAGE Therapeutics (SAGE) Reports Q2 Loss of $0.36
May 3, 2018 06:38 AM SAGE Therapeutics (SAGE) Tops Q1 EPS by 16c
Feb 22, 2018 06:30 AM SAGE Therapeutics (SAGE) Tops Q4 EPS by 24c
Feb 7, 2018 06:34 AM SAGE Therapeutics (SAGE) SAGE-217 Granted FDA Breakthrough Therapy Designation for Major Depressive Disorder
Nov 2, 2017 06:35 AM SAGE Therapeutics (SAGE) Reports In-Line Q3 EPS
Sep 12, 2017 06:08 AM SAGE Therapeutics (SAGE) Top-Line Results from Phase 3 STATUS Trial of Brexanolone Misses Primary Endpoint
Aug 3, 2017 05:38 PM SAGE Therapeutics (SAGE) Misses Q2 EPS by 21c
May 9, 2017 05:15 PM SAGE Therapeutics (SAGE) Tops Q1 EPS by 9c
Nov 3, 2016 08:23 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 5c
Aug 9, 2016 06:43 AM SAGE Therapeutics (SAGE) Misses Q2 EPS by 6c; Readout of Phase 3 STATUS Trial in SRSE Now Expected in 1H 2017
Aug 12, 2015 06:32 AM SAGE Therapeutics (SAGE) Misses Q2 EPS by 22c
May 14, 2015 06:33 AM SAGE Therapeutics (SAGE) Misses Q1 EPS by 17c
Feb 27, 2015 06:31 AM SAGE Therapeutics (SAGE) Posts Q4 Loss of ~$1.57/Share
Nov 11, 2014 07:09 AM SAGE Therapeutics (SAGE) Misses Q3 EPS by 10c
Aug 14, 2014 06:46 AM Sage Therapeutics (SAGE) Posts Q2 Loss of $4.57/Share

Back to SAGE Stock Lookup